Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

489 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
RacGAP1 Is a Novel Downstream Effector of E2F7-Dependent Resistance to Doxorubicin and Is Prognostic for Overall Survival in Squamous Cell Carcinoma.
Hazar-Rethinam M, de Long LM, Gannon OM, Boros S, Vargas AC, Dzienis M, Mukhopadhyay P, Saenz-Ponce N, Dantzic DD, Simpson F, Saunders NA. Hazar-Rethinam M, et al. Among authors: simpson f. Mol Cancer Ther. 2015 Aug;14(8):1939-50. doi: 10.1158/1535-7163.MCT-15-0076. Epub 2015 May 27. Mol Cancer Ther. 2015. PMID: 26018753
An Ex Vivo Human Tumor Assay Shows Distinct Patterns of EGFR Trafficking in Squamous Cell Carcinoma Correlating to Therapeutic Outcomes.
Joseph SR, Gaffney D, Barry R, Hu L, Banushi B, Wells JW, Lambie D, Strutton G, Porceddu SV, Burmeister B, Leggatt GR, Schaider H, Dolcetti R, Frazer IH, Saunders NA, Foote M, Soyer HP, Simpson F. Joseph SR, et al. Among authors: simpson f. J Invest Dermatol. 2019 Jan;139(1):213-223. doi: 10.1016/j.jid.2018.06.190. Epub 2018 Aug 2. J Invest Dermatol. 2019. PMID: 30077724 Free article.
Clinically-Relevant Rapamycin Treatment Regimens Enhance CD8+ Effector Memory T Cell Function In The Skin and Allow their Infiltration into Cutaneous Squamous Cell Carcinoma.
Jung JW, Veitch M, Bridge JA, Overgaard NH, Cruz JL, Linedale R, Franklin ME, Saunders NA, Simpson F, Frazer IH, Steptoe RJ, Wells JW. Jung JW, et al. Among authors: simpson f. Oncoimmunology. 2018 Jul 30;7(9):e1479627. doi: 10.1080/2162402X.2018.1479627. eCollection 2018. Oncoimmunology. 2018. PMID: 30228949 Free PMC article.
Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies.
Chew HY, De Lima PO, Gonzalez Cruz JL, Banushi B, Echejoh G, Hu L, Joseph SR, Lum B, Rae J, O'Donnell JS, Merida de Long L, Okano S, King B, Barry R, Moi D, Mazzieri R, Thomas R, Souza-Fonseca-Guimaraes F, Foote M, McCluskey A, Robinson PJ, Frazer IH, Saunders NA, Parton RG, Dolcetti R, Cuff K, Martin JH, Panizza B, Walpole E, Wells JW, Simpson F. Chew HY, et al. Among authors: simpson f. Cell. 2020 Mar 5;180(5):895-914.e27. doi: 10.1016/j.cell.2020.02.019. Cell. 2020. PMID: 32142680 Free article.
The voltage gated Ca(2+)-channel Cav3.2 and therapeutic responses in breast cancer.
Pera E, Kaemmerer E, Milevskiy MJG, Yapa KTDS, O'Donnell JS, Brown MA, Simpson F, Peters AA, Roberts-Thomson SJ, Monteith GR. Pera E, et al. Among authors: simpson f. Cancer Cell Int. 2016 Mar 31;16:24. doi: 10.1186/s12935-016-0299-0. eCollection 2016. Cancer Cell Int. 2016. PMID: 27034617 Free PMC article.
489 results